Pages that link to "Q30611958"

The following pages link to Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I. (Q30611958):

Displaying 39 items.

• Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study (Q24630222) (← links)
• Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies (Q26865740) (← links)
• Magnetic resonance spectroscopy: current and future applications in psychiatric research (Q30673059) (← links)
• A review of neuroimaging studies of young relatives of individuals with schizophrenia: a developmental perspective from schizotaxia to schizophrenia (Q30678998) (← links)
• Magnetic resonance spectroscopy and its applications in psychiatry (Q30684591) (← links)
• Neuroanatomy and neurophysiology in schizophrenia (Q30698640) (← links)
• Assessing brain development using neurophysiologic and behavioral measures (Q30883467) (← links)
• Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia (Q30884291) (← links)
• Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology (Q30949960) (← links)
• In vivo imaging of neuroinflammation in schizophrenia (Q30966978) (← links)
• Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study (Q31114435) (← links)
• Deconstructing psychosis with human brain imaging (Q31114592) (← links)
• In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders (Q32115381) (← links)
• Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy (Q33186072) (← links)
• N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology (Q33271816) (← links)
• Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II. (Q34026108) (← links)
• Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study (Q34238730) (← links)
• The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. (Q34778242) (← links)
• Magnetic resonance spectroscopy and neurocognitive dysfunction in obstructive sleep apnea before and after CPAP treatment (Q35623532) (← links)
• Evidence of developmental alterations in cortical and subcortical regions of children with attention-deficit/hyperactivity disorder: a multivoxel in vivo phosphorus 31 spectroscopy study (Q35657328) (← links)
• Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? (Q36814158) (← links)
• A proton spectroscopy study of white matter in children with autism (Q40290522) (← links)
• 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration (Q40495933) (← links)
• Neurochemical brain imaging studies in bipolar disorder (Q40547090) (← links)
• Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study (Q40597899) (← links)
• Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study (Q42446017) (← links)
• Wilson's disease: (31)P and (1)H MR spectroscopy and clinical correlation (Q42467592) (← links)
• Advanced magnetic resonance imaging in benign hereditary chorea: study of two familial cases. (Q42476368) (← links)
• Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. (Q43940200) (← links)
• Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. (Q43992279) (← links)
• Metabolite alterations in basal ganglia associated with psychiatric symptoms of abstinent toluene users: a proton MRS study (Q44811413) (← links)
• In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest (Q44980276) (← links)
• Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia. (Q48266484) (← links)
• Elevated Choline-Containing Compound Levels in Rapid Cycling Bipolar Disorder. (Q53656292) (← links)
• Lower Choline-Containing Metabolites/Creatine (Cr) Rise and Failure to Sustain NAA/Cr Levels in the Dorsolateral Prefrontal Cortex Are Associated with Depressive Episode Recurrence under Maintenance Therapy: A Proton Magnetic Resonance Spectroscopy (Q89846120) (← links)
• Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study (Q90350386) (← links)
• The Assertive Brain: Anterior Cingulate Phosphocreatine plus Creatine Levels Correlate With Self-Directedness in Healthy Adolescents (Q91893883) (← links)
• Automated Voxel Placement: A Linux-based Suite of Tools for Accurate and Reliable Single Voxel Coregistration (Q94063653) (← links)
• Altered neurochemistry in the anterior white matter of bipolar children and adolescents: a multivoxel 1H MRS study (Q101564359) (← links)